0001209191-21-006781.txt : 20210202
0001209191-21-006781.hdr.sgml : 20210202
20210202162659
ACCESSION NUMBER: 0001209191-21-006781
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210202
DATE AS OF CHANGE: 20210202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Forster Eliot
CENTRAL INDEX KEY: 0001831558
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 21581801
MAIL ADDRESS:
STREET 1: C/O EDDEVA B920
STREET 2: BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: F-star Therapeutics, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
BUSINESS PHONE: 44 1223 497400
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: BABRAHAM RESEARCH CAMPUS
CITY: CAMBRIDGE
STATE: X0
ZIP: CB22 3AT
FORMER COMPANY:
FORMER CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20130108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-01
0
0001566373
F-star Therapeutics, Inc.
FSTX
0001831558
Forster Eliot
C/O F-STAR THERAPEUTICS, INC.
EDDEVA B920, BABRAHAM RESEARCH CAMPUS
CAMBRIDGE
X0
CB22 3AT
UNITED KINGDOM
1
1
0
0
President and CEO
Common Stock
2021-02-01
4
A
0
142000
0.00
A
160560
D
The securities awarded are in the form of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the
Issuer's common stock. 25% of the shares shall vest on the one-year anniversary of the date of the grant, and thereafter shall vest in equal monthly installments over the remaining three years.
Includes 142,000 RSUs.
/s/ Darlene Deptula-Hicks, Attorney-in-fact
2021-02-02